Amplia Therapeutics Ltd. (AU:ATX) has released an update.
Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
Amplia Therapeutics Ltd. has successfully raised approximately A$9.9 million through its institutional placement and entitlement offer, attracting strong demand from both existing and new investors. The company is also set to launch a fully underwritten retail entitlement offer, giving shareholders the opportunity to purchase new shares with attaching options. These financial moves aim to support Amplia’s goals in advancing its pancreatic cancer trials.
For further insights into AU:ATX stock, check out TipRanks’ Stock Analysis page.